Check-Cap Stock Price, News & Analysis (NASDAQ:CHEK) $2.70 -0.02 (-0.74%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$2.62▼$2.8750-Day Range$2.61▼$4.0752-Week Range$1.22▼$5.90Volume7,373 shsAverage Volume15,639 shsMarket Capitalization$13.01 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Check-Cap MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside159.3% Upside$7.00 Price TargetShort InterestHealthy1.27% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.71Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.28) to ($0.99) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.19 out of 5 starsMedical Sector348th out of 933 stocksX - Ray Apparatus & Tubes Industry4th out of 6 stocks 3.0 Analyst's Opinion Consensus RatingCheck-Cap has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $7.00, Check-Cap has a forecasted upside of 159.3% from its current price of $2.70.Amount of Analyst CoverageCheck-Cap has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.27% of the float of Check-Cap has been sold short.Short Interest Ratio / Days to CoverCheck-Cap has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Check-Cap has recently decreased by 23.11%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCheck-Cap does not currently pay a dividend.Dividend GrowthCheck-Cap does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CHEK. Previous Next 3.2 News and Social Media Coverage News SentimentCheck-Cap has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Check-Cap this week, compared to 1 article on an average week.Search Interest1 people have searched for CHEK on MarketBeat in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Check-Cap insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.48% of the stock of Check-Cap is held by insiders.Percentage Held by InstitutionsOnly 0.21% of the stock of Check-Cap is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Check-Cap are expected to grow in the coming year, from ($2.28) to ($0.99) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Check-Cap is -0.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Check-Cap is -0.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCheck-Cap has a P/B Ratio of 0.32. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Check-Cap Stock (NASDAQ:CHEK)Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.Read More CHEK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHEK Stock News HeadlinesDecember 9, 2023 | americanbankingnews.comCheck-Cap (NASDAQ:CHEK) Receives New Coverage from Analysts at StockNews.comDecember 8, 2023 | finance.yahoo.comCITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEESDecember 10, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. December 7, 2023 | finance.yahoo.comLeading Independent Proxy Advisory Firm ISS Recommends Check-Cap Shareholders Vote FOR the Keystone Dental Business Combination AgreementDecember 5, 2023 | finance.yahoo.comCHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEESDecember 1, 2023 | americanbankingnews.comStockNews.com Begins Coverage on Check-Cap (NASDAQ:CHEK)November 29, 2023 | benzinga.comCheck-Cap Stock (NASDAQ:CHEK) Earnings Dates and Earning CallsNovember 28, 2023 | benzinga.comCheck-Cap Stock (NASDAQ:CHEK) Dividends: History, Yield and DatesDecember 10, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 27, 2023 | msn.comCheck-Cap GAAP EPS of -$0.44November 27, 2023 | benzinga.comCheck-Cap: Q3 Earnings InsightsNovember 27, 2023 | markets.businessinsider.comCheck-Cap Posts Narrower Loss In Q3 - Quick FactsNovember 27, 2023 | finance.yahoo.comCheck-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate UpdateNovember 7, 2023 | morningstar.comCheck-Cap Ltd CHEKOctober 31, 2023 | markets.businessinsider.comNotice of Extraordinary General Meeting of ShareholdersOctober 27, 2023 | msn.comCheck out some of the caps you can get at a Bucks game this yearOctober 26, 2023 | bloomberg.comKazakhstan Aims to Cut Loan-Rate CapOctober 19, 2023 | finance.yahoo.comCheck-Cap Issues Letter to Shareholders Regarding Proposed Merger with Keystone Dental HoldingsSeptember 21, 2023 | finance.yahoo.comSYMETRYX OPPOSES CHEK CAP/KEYSTONE MERGER, WILL EVALUATE OPTIONS TO STOP TRANSACTIONSeptember 19, 2023 | barrons.comCheck-Cap Ltd.August 17, 2023 | seekingalpha.comCheck-Cap to combine with Keystone Dental HoldingsAugust 17, 2023 | marketwatch.comCheck-Cap Shares Fall After Striking Merger With Keystone DentalAugust 5, 2023 | finanznachrichten.deCheck-Cap Ltd.: Check-Cap Reports Second Quarter 2023 Financial ResultsAugust 4, 2023 | finance.yahoo.comCheck-Cap Reports Second Quarter 2023 Financial ResultsJuly 27, 2023 | marketwatch.comCheck-Cap Shares Rise 12% After Symetryx Raises Buyout OfferJuly 25, 2023 | finance.yahoo.comSYMETRYX CORP INCREASES NON-BINDING OFFER TO ACQUIRE CHECK-CAP TO $4.60 PER SHAREJuly 19, 2023 | seekingalpha.comCheck-Cap jumps after Symetryx $4.35/share takeover offerSee More Headlines Receive CHEK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/27/2023Today12/10/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/29/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry X - ray apparatus & tubes Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CHEK CUSIPN/A CIK1610590 Webwww.check-cap.com Phone972546706451Fax972-4821-1267Employees85Year FoundedN/APrice Target and Rating Average Stock Price Target$7.00 High Stock Price Target$7.00 Low Stock Price Target$7.00 Potential Upside/Downside+159.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($3.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,110,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-47.85% Return on Assets-43.50% Debt Debt-to-Equity RatioN/A Current Ratio17.60 Quick Ratio17.60 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$8.57 per share Price / Book0.32Miscellaneous Outstanding Shares4,820,000Free Float4,798,000Market Cap$13.01 million OptionableNot Optionable Beta0.34 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Alex Ovadia (Age 61)CEO & Director Comp: $409.35kDr. Yoav Kimchy Ph.D. (Age 62)Founder & Chief Technology Officer Comp: $362.65kMs. Mira Rosenzweig (Age 51)Chief Financial Officer Comp: $287.99kMr. Joshua Belkar (Age 54)Vice President of Operations Comp: $269.57kMs. Noa Reshef M.B.A.Director of Human ResourcesKey CompetitorsT2 BiosystemsNASDAQ:TTOOAIkido PharmaNASDAQ:AIKIBioNexus Gene LabNASDAQ:BGLCHillstream BioPharmaNASDAQ:HILSMustang BioNASDAQ:MBIOView All Competitors CHEK Stock Analysis - Frequently Asked Questions Should I buy or sell Check-Cap stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Check-Cap in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CHEK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHEK, but not buy additional shares or sell existing shares. View CHEK analyst ratings or view top-rated stocks. What is Check-Cap's stock price target for 2024? 1 Wall Street analysts have issued twelve-month price objectives for Check-Cap's stock. Their CHEK share price targets range from $7.00 to $7.00. On average, they expect the company's stock price to reach $7.00 in the next year. This suggests a possible upside of 159.3% from the stock's current price. View analysts price targets for CHEK or view top-rated stocks among Wall Street analysts. How have CHEK shares performed in 2023? Check-Cap's stock was trading at $2.20 on January 1st, 2023. Since then, CHEK shares have increased by 22.7% and is now trading at $2.70. View the best growth stocks for 2023 here. Are investors shorting Check-Cap? Check-Cap saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 66,200 shares, a decline of 23.1% from the October 31st total of 86,100 shares. Based on an average trading volume of 44,400 shares, the days-to-cover ratio is currently 1.5 days. Currently, 1.3% of the shares of the stock are sold short. View Check-Cap's Short Interest. When is Check-Cap's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024. View our CHEK earnings forecast. How were Check-Cap's earnings last quarter? Check-Cap Ltd. (NASDAQ:CHEK) released its quarterly earnings results on Monday, November, 27th. The medical research company reported ($0.44) earnings per share for the quarter, beating the consensus estimate of ($0.83) by $0.39. When did Check-Cap's stock split? Check-Cap shares reverse split on the morning of Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Check-Cap own? Based on aggregate information from My MarketBeat watchlists, some companies that other Check-Cap investors own include Alibaba Group (BABA), Navios Maritime Partners (NMM), New Residential Investment (NRZ), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Acasti Pharma (ACST), Avinger (AVGR), Biocept (BIOC) and Purple Biotech (KTOV). When did Check-Cap IPO? (CHEK) raised $13 million in an IPO on Thursday, February 19th 2015. The company issued 1,200,000 shares at a price of $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group acted as the underwriters for the IPO and Feltl and Company was co-manager. How do I buy shares of Check-Cap? Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:CHEK) was last updated on 12/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Check-Cap Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.